Latest Working Capital News

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Coronado Global Resources has agreed to sell its Logan Mining Complex in West Virginia for nominal cash consideration, shifting liabilities to the buyer and aiming to sharpen focus on core metallurgical coal assets.

Corella Resources has completed due diligence on the Chobe Project tenements, advancing its plan to acquire a 75% stake from Caprice Resources. The project, rich in carbonatite potential, awaits final capital raising and regulatory approvals.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.

PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.

SPC Global has launched a fully underwritten entitlement offer to raise approximately $97.1 million at 10 cents per share, aiming to reduce debt and support working capital.

MaxiPARTS has seen activity levels dip due to the Middle East conflict but expects to maintain profit margins through cost controls and a resilient Förch Australia segment.

Fletcher Building has cleared a major hurdle in its divestment strategy, with the sale of its Construction Division to VINCI Construction now unconditional and the purchase price rising to about $334 million.

Oceania Healthcare Limited has delivered a standout FY26 with 16% higher sales, 20% EBITDA growth, and a 19% reduction in net debt, setting the stage for positive cash flow in FY27 despite no dividend declared this year.

Findi Limited lowers its FY26 operating revenue and EBITDA guidance, citing integration costs and funding delays, but reports operational improvements following a $25 million equity raise and appoints a new Chief Commercial Officer.